PubMed=8459226; DOI=10.1084/jem.177.4.989; PMCID=PMC2190978
Andrea Anichini, Cristina Maccalli, Roberta Mortarini, Stefania Salvi, Arabella Mazzocchi, Paola Squarcina, Meenhard Herlyn, Giorgio Parmiani;
Melanoma cells and normal melanocytes share antigens recognized by HLA-A2-restricted cytotoxic T cell clones from melanoma patients.
J. Exp. Med. 177:989-998(1993)

PubMed=9743519; DOI=10.1084/jem.188.6.1005; PMCID=PMC2212536
Raffaella Lupetti, Patrizia Pisarra, Alessandro Verrecchia, Cinthia Farina, Gabriella Nicolini, Andrea Anichini, Claudio Bordignon, Marialuisa Sensi, Giorgio Parmiani, Catia Traversari;
Translation of a retained intron in tyrosinase-related protein (TRP) 2 mRNA generates a new cytotoxic T lymphocyte (CTL)-defined and shared human melanoma antigen not expressed in normal cells of the melanocytic lineage.
J. Exp. Med. 188:1005-1016(1998)

DOI=10.13130/grazia-giulia_phd2016-02-18
Giulia Grazia;
Co-targeting of oncogenic and death receptors pathways in human melanoma: pre-clinical rationale for a pro-apoptotic and anti-angiogenic strategy.
Thesis PhD (2015); Universita degli studi di Milano; Milano; Italy

PubMed=25576923; DOI=10.18632/oncotarget.2995; PMCID=PMC4413617
Rossella Loria, Giulia Bon, Valentina Perotti, Enzo Gallo, Ilaria Bersani, Paola Baldassari, Manuela Porru, Carlo Leonetti, Selene Di Carlo, Paolo Visca, Maria Felice Brizzi ...Show all 14 authors... , Andrea Anichini, Roberta Mortarini, Rita Falcioni; Show fewer authors
Sema6A and Mical1 control cell growth and survival of BRAFV600E human melanoma cells.
Oncotarget 6:2779-2793(2015)